Latest Compliance News

Emerald Resources has announced a 27% increase in the Mineral Resource Estimate for its Memot Gold Project in Cambodia, now totaling 1.7 million ounces of gold, with full permitting in place to begin development this year.

Noxopharm has successfully completed the final multiple-dose cohort of its HERACLES trial for SOF-SKN™, reporting no significant safety concerns and paving the way for Phase II-enabling studies.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

Eagle Mountain Mining has launched a Placement Options Offer for 61.3 million options attaching to recent placement shares, potentially raising $1.23 million upon exercise. The offer supports ongoing exploration and strategic initiatives in Arizona copper projects.

Neurizon Therapeutics has secured trademark protection for its NEURIZON® brand across major pharmaceutical markets, reinforcing its intellectual property strategy as it advances its lead drug candidate NUZ-001.

FBR Limited has secured a binding conditional purchase order worth AUD 990,000 from a leading US heavy equipment dealer for its Mantis welding robot, marking a significant milestone during its prototyping phase.

American Uranium's recent hydrogeological pump tests at the Lo Herma project validate key aquifer properties consistent with nearby operating ISR uranium mines, supporting upcoming resource and scoping study updates.

Bellevue Gold Limited reported a robust cash flow and significant debt reduction in its December 2025 quarter, ending with a strong cash position of A$165.1 million. The company made early principal repayments on its project loan facility, lowering outstanding debt to A$100 million.

Richmond Vanadium Technology Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information is driving the activity and attributing the surge to broader market interest and improved liquidity.

The a2 Milk Company has responded to an ASX price query denying any undisclosed information behind recent share price moves, attributing the volatility to China’s latest birth statistics.

Phoslock Environmental Technologies has amended its December 2025 quarterly report to correct funding data and withdraw its sales outlook, while reporting improved cash flow and resuming factory operations.

Alice Queen Limited has addressed a recent doubling in its share price, attributing the surge to rising gold prices and ongoing project developments rather than undisclosed information.